These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35822673)
41. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593 [TBL] [Abstract][Full Text] [Related]
42. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Woodworth MH; Kraft CS; Meredith EJ; Mehta AK; Wang T; Mamo YT; Dhere T; Sitchenko KL; Patzer RE; Friedman-Moraco RJ Transpl Infect Dis; 2018 Apr; 20(2):e12857. PubMed ID: 29446866 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients. Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013 [TBL] [Abstract][Full Text] [Related]
44. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546 [TBL] [Abstract][Full Text] [Related]
45. Effectiveness of the Combination of Everolimus and Tacrolimus With High Dosage of Mizoribine for Living Donor-Related Kidney Transplantation. Yoshimura N; Nakao T; Nakamura T; Harada S; Koshino K; Suzuki T; Ito T; Nobori S; Ushigome H Transplant Proc; 2016 Apr; 48(3):786-9. PubMed ID: 27234736 [TBL] [Abstract][Full Text] [Related]
46. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Pereira MR; Arcasoy S; Farr MA; Mohan S; Emond JC; Tsapepas DS; Shi Q; Purpura L; Uhlemann AC; Zucker J; Verna EC Transpl Infect Dis; 2021 Aug; 23(4):e13637. PubMed ID: 33993630 [TBL] [Abstract][Full Text] [Related]
47. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103 [TBL] [Abstract][Full Text] [Related]
48. Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients. Fox BD; Ashquar F; Raviv Y; Rozengarten D; Straichman O; Izhakian S; Kramer MR Ann Transplant; 2017 Nov; 22():677-681. PubMed ID: 29133776 [TBL] [Abstract][Full Text] [Related]
49. Sublingual administration of tacrolimus: current trends and available evidence. Doligalski CT; Liu EC; Sammons CM; Silverman A; Logan AT Pharmacotherapy; 2014 Nov; 34(11):1209-19. PubMed ID: 25251980 [TBL] [Abstract][Full Text] [Related]
50. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Kuypers DR Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747 [TBL] [Abstract][Full Text] [Related]
54. Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients. Choong CL; Wong HS; Lee FY; Lee CK; Kho JV; Lai YX; Vikneswaran T Transplant Proc; 2018 Oct; 50(8):2515-2520. PubMed ID: 30316389 [TBL] [Abstract][Full Text] [Related]
55. Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients. Azam F; Khan M; Bhatti ABH; Dar FS; Ahmad A; Javed N J Coll Physicians Surg Pak; 2019 Nov; 29(11):1048-1052. PubMed ID: 31659960 [TBL] [Abstract][Full Text] [Related]
56. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients. Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715 [TBL] [Abstract][Full Text] [Related]
57. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis. Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543 [TBL] [Abstract][Full Text] [Related]
58. Converting immunosuppression from an oral suspension to a granule formulation of tacrolimus in pediatric renal transplant recipients. Malakasioti G; Booth C; Marks SD Pediatr Transplant; 2018 Aug; 22(5):e13214. PubMed ID: 29767471 [TBL] [Abstract][Full Text] [Related]
59. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients. Griffin SP; Nelson JE Prog Transplant; 2016 Dec; 26(4):314-321. PubMed ID: 27628498 [TBL] [Abstract][Full Text] [Related]
60. The Association of Tacrolimus Formulation Switching with Trough Concentration Variability: A Retrospective Cohort Study of Tacrolimus Use Post-Kidney Transplantation Based on National Drug Code (NDC) Numbers. Schwartz JJ; Lee E; Butler AP; Facklam DP; Franks B; Spalding JR; Vassilakis ME; Thal GD; Irish WD Adv Ther; 2019 Jun; 36(6):1358-1369. PubMed ID: 31004326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]